Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this one year extension (follow-up) study is to gather additional safety data
in hypogonadal men treated with oral TU or AndroGel who have completed the 12-month Phase III
study CLAR-09007.